Dimensional Fund Advisors
OMIC

Dimensional Fund Advisors’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Dimensional Fund Advisors’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-637
Closed -$23.1K – 3525
2023
Q1 		$23.1K Buy
+637
New +$39K ﹤0.01% 3431

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors's OMIC Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2023, closing a stake of 637 shares — an estimated $23.1K sold.

Dimensional Fund Advisors first reported a position in OMIC in Q1 2023 and held it in 1 quarter. The position peaked at $23.1K in Q1 2023. 62 funds tracked by Wall St. Rank hold OMIC as of Q2 2023.

  • Dimensional Fund Advisors reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 637 Singular Genomics Systems, Inc. Common Stock shares in Q2 2023, an estimated $23.1K.
  • Dimensional Fund Advisors first reported a position in Singular Genomics Systems, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Dimensional Fund Advisors's Singular Genomics Systems, Inc. Common Stock position peaked at $23.1K in Q1 2023.
  • 62 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.